Dan Rather talks with IGI Executive Director Jennifer Doudna about her development of CRISPR-Cas9 technology, the breakthrough genomic engineering tool that is now being used by researchers worldwide to study a wide range of applications in biomedicine, human health, agriculture and bioenergy.
During their candid conversation, Dr. Doudna talks about her early education, her decision to become a scientist, and how key mentors and collaborators have inspired her research. She also emphasized the importance of caution and the necessity for a “public conversation” to raise awareness of the ethical and regulatory issues that will need to be carefully considered in light of this powerful new technology.
Conversations in Science with Dan Rather & Jennifer Doudna: CRISPR
iBiology | Dan Rather | September 7, 2016